Topics in Drug Testing from Quest Diagnostics

During each of the last three years more than 100,000 people have died from drug overdoses in the United States. During this same time period, there has been a significant increase in patients suffering from mental health conditions. Today in the US, nearly 50 million patients are prescribed medications for mental health conditions, and that number is growing. Many of these medications are scheduled drugs / controlled substances. Drug testing is a critical tool to help monitor medication adherence for patients taking these medications. Drug testing can help in establishing a baseline for patients and help identify medication use or non-use, detect use of illicit substances, and help to prevent potential drug-drug interactions and harmful poly-substance use. Today’s Topics in Drug Testing podcast episode will cover: You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series, please visit QuestDrugTesting.com. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Drug testing plays a critical role in combating the drug misuse epidemic. There are 2 main methods of clinical drug testing: presumptive testing, which includes rapid point-of-care (POC) devices as well as more sensitive laboratory immunoassays; and definitive testing, which uses highly complex laboratory instruments to identify and quantify prescription medications, illicit substances, and specific parent drugs and their metabolites, often missed by POC testing. In today’s podcast episode, Quest Drug Monitoring & Toxicology experts will cover: You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series, please visit QuestDrugTesting.com. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Today’s episode is with Quest Diagnostics senior medical advisor, Dr Jeff Gudin, and Dr Jack Kain, director and medical science liaison for the Quest Drug Monitoring and Toxicology business. The podcast will cover: You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series, please visit QuestDrugTesting.com. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.

Welcome to the Quest Diagnostics “topics in drug testing” podcast. Today’s episode is with Quest Diagnostics senior medical advisor, Dr Jeff Gudin, and Dr Jack Kain, director and medical science liaison for the Quest Drug Monitoring and Toxicology business. The podcast will cover: You may download a PDF of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series, please visit QuestDrugTesting.com. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.

Learning objectives for the podcast include: You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series or learn more about the comprehensive drug testing offering from Quest Diagnostics, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions. 1. Bahr R, Lopez A, Rey JA. Intranasal Esketamine(SpravatoTM) for use in treatment-resistant depression In conjunction with an oral antidepressant.P&T. 2019;44(6):340-375.

Objectives for the podcast include: You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series or learn more about the comprehensive drug testing offering from Quest Diagnostics, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Objectives for the podcast include: You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series or learn more about the comprehensive drug testing offering from Quest Diagnostics, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.

Today’s podcast will cover a substance of great concern today, fentanyl. We will discuss and share information regarding the following: The episode will feature Quest Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series, or learn more about Quest Diagnostics’ comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Today’s podcast will cover the value of prescription and illicit drug testing and provide insight on the different clinical drug testing methodologies. We will discuss and share information regarding the following: The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin; Medical Science Liaison Jack Kain, PharmD; and Executive Science Director, Les Edinboro, PhD. ----more---- You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series, or learn more about Quest Diagnostics’ comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

The convergence of the opioid epidemic and the coronavirus disease 2019 (COVID-19) pandemic has created new healthcare challenges. Health systems, from a system- and individual clinician-level, are more important than ever in the pursuit of addressing the epidemic within the pandemic. In this session, Dr Gudin discusses with Dr Pat Alagia on the Quest Dialogues podcast: ----more---- About Dr Pat Alagia As an entrepreneurial, innovative, and forward-thinking physician executive, Dr Alagia has developed extensive experience and deep expertise throughout the healthcare ecosystem through his many years in the health system C-Suite and as a Senior Executive in major medical companies. He has led large complex academically based regional healthcare systems, for-profit and not-for-profit healthcare organizations, venture capital-backed healthcare companies, and small and large clinical practices. Today as the Chief Clinical Officer for Hospitals and Health Systems and as a Senior Medical Director for core and advanced at Quest Diagnostics, Dr Alagia and his clinical, scientific, academic, and commercial colleagues focus on a variety of topics involving diagnostic testing and patient care across the care continuum. He and his team are passionately committed to patient care, clinical and scientific excellence, and building interdisciplinary collegial relationships.

Today’s podcast discussion will focus on clinical care for patients with mental health disorders. Will discuss and share information regarding: The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin; Medical Liaison Jack Kain, PharmD; and Director, Medical Science Liaison—Neurology and Pharmacogenomics, Raymond Lorenz. ----more---- You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series, or learn more about Quest Diagnostics’ comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Today’s podcast discussion will focus on appropriate steps to take to implement an effective Drug Monitoring Protocol in your practice. Key information shared will include: The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin; Medical Liaison Jack Kain, PharmD; and Senior Product Manager Jason Suomala, for the Quest Diagnostics Drug Monitoring and Toxicology division. ----more---- You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series, or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Today’s podcast discussion will focus on the importance of drug monitoring and the benefits of “alternative” sample collection options during the COVID-19 pandemic. Key information shared will include: The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin, and Jason Suomala, Senior Product Manager for the Quest Diagnostics Drug Monitoring and Toxicology division. ----more---- You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Today’s podcast will share results of a recent Quest Diagnostics Health Trends™ publication, The Opioid Epidemic Within the COVID-19 Pandemic: Drug Monitoring in 2020, which was published in the October 2020 edition of Population Health Management. The study objective was to better understand the relationship between the COVID-19 pandemic and the drug epidemic in the US. To achieve this objective, investigators analyzed urine specimen results from an analytic cohort of 872,762 specimens from all 50 states and the District of Columbia. Findings demonstrated significant changes in prescription drug monitoring and positivity rates for many drugs of concern. Important study results and conclusions discussed will include: This episode features Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology, and Justin Niles, lead medical informatics analyst for Quest Diagnostics Health Trends™. ----more---- You may download a PDF version of this presentation here >>

Today’s podcast will cover drug testing for stimulants and will highlight some of the challenges in results interpretation for this class of drugs. Important information shared during the discussion will include: The episode features Dr Les Edinboro, PhD, executive science director, and Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology. ----more---- You may download a PDF version of this presentation here >> To listen to other podcasts in our “Topics in Drug Testing” series, or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.

Today’s podcast will cover the role of clinical drug monitoring in Behavioral Health and during times of crisis. Important information shared will include: The episode features Dr Jeff Gudin, senior medical advisor and Dr Jack Kain, medical science liaison for the Quest Diagnostics Drug Monitoring and Toxicology division. ----more---- You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Today’s podcast will cover key findings from the annual Quest Diagnostics Health Trends report, Drug Misuse in America. Some of the key topics shared will include: This episode features Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology, and Justin Niles, lead medical informatics analyst for Quest Diagnostics Health Trends™. ----more---- You may download a PDF version of this presentation here>> To listen to other podcasts in our series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Today’s podcast will cover testing for kratom, a drug of concern. Some of the key information shared will include: This episode features Jack Kain, PharmD, Quest Diagnostics medical science liaison, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring. ----more---- You may download a PDF version of this presentation here>> To listen to other podcasts in our series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Today's podcast will cover why and when to use oral fluid testing. Some key topics shared will include: The episode features Les Edinboro, PhD, Quest Diagnostics executive science director, toxicology and drug monitoring, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring. ----more---- You may download a PDF version of this presentation here >> Download the oral fluid specimen collection instructions PDF here >> Download the oral fluid testing brochure PDF here >> To listen to other podcasts in our series or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Today’s podcast will cover dangerous drug combinations and the role of clinical drug monitoring. Some of the key information that will be shared includes: This episode features Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. ----more---- You may download the PDF version of this presentation here>> To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.